Invention Grant
- Patent Title: Phosphoramidate alkylator prodrugs
-
Application No.: US14102213Application Date: 2013-12-10
-
Publication No.: US09226932B2Publication Date: 2016-01-05
- Inventor: Mark Matteucci , Jian-Xin Duan , Hailong Jiao
- Applicant: Threshold Pharmaceuticals, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Threshold Pharmaceuticals, Inc.
- Current Assignee: Threshold Pharmaceuticals, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Kilpatrick Townsend & Stockton LLP
- Main IPC: A61K31/337
- IPC: A61K31/337 ; A61K31/675 ; A61K33/24 ; C07F9/6506 ; C07F9/6539 ; A61K31/513 ; A61K31/7068
Abstract:
Phosphoramidate alkylator prodrugs can be used to treat cancer when administered alone or in combination with one or more anti-neoplastic agents.
Public/Granted literature
- US20140170240A1 Phosphoramidate Alkylator Prodrugs Public/Granted day:2014-06-19
Information query
